kaiser permanente glp-1 coverage news drugs will cost $50 a month through Medicare for some 📌 Starting January 1, 2025,

Secure & Encrypted Thank you

Patients with a history of severe gastroparesis are generally advised against using GLP-1 receptor agonists

Expanded obesity drug coverage can increase Medicaid spending and put pressure on overall state budgets, and states are now facing tighter budget conditions and longer-term fiscal uncertainty, due in part to the federal Medicaid cuts in the 2025 reconciliation law, causing state Medicaid programs to re-evaluate their obesity drug coverage

There is currently no requirement for ACA plans to cover weight loss medications, but a growing number of plans including employer-sponsored and self-funded plans do cover medications like Zepbound and Wegovy

GLP-1 drugs can help with weight loss, but they arent without risks

Get daily updates from WHYY News